Search research articles
Contact Us
Filters
Showing results (1-10 of 217) with videos related to
Page
of 22
Sort By:
Biomedical Journal
|
May 22, 2025
Overview: PAI-1 inhibitors and clinical applications
Toshio Miyata
Polskie Archiwum Medycyny Wewnetrznej
|
May 6, 2009
Novel mechanisms and therapeutic options in diabetic nephropathy
Toshio Miyata
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 16, 2008
[Mechanisms in remodeling of the kidney]
Masaomi Nangaku, Toshio Miyata
Diabetes Research and Clinical Practice
|
October 29, 2008
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Toshio Miyata, Takashi Dan
Advances in Renal Replacement Therapy
|
December 19, 2003
Advanced glycation end products in uremia
Thomas Henle, Toshio Miyata
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 4, 2007
Toward better renoprotection: lessons from angiotensin receptor blockers
Toshio Miyata, Shunya Takizawa
Internal Medicine (Tokyo, Japan)
|
January 13, 2004
A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy
Toshio Miyata, Kiyoshi Kurokawa
Annals of the New York Academy of Sciences
|
May 2, 2008
Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Toshio Miyata, Yuko Izuhara
Cells
|
May 27, 2026
Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614
Mohamed Abdelhakim, Toshio Miyata
Amino Acids
|
October 21, 2010
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
Casper G Schalkwijk, Toshio Miyata
Page
of 22
Search research articles
Search
Showing results (1-10 of 217) with videos related to
Sort By:
Page
of 22
Biomedical Journal
|
May 22, 2025
Overview: PAI-1 inhibitors and clinical applications
Toshio Miyata
Polskie Archiwum Medycyny Wewnetrznej
|
May 6, 2009
Novel mechanisms and therapeutic options in diabetic nephropathy
Toshio Miyata
Nihon Rinsho. Japanese Journal of Clinical Medicine
|
September 16, 2008
[Mechanisms in remodeling of the kidney]
Masaomi Nangaku, Toshio Miyata
Diabetes Research and Clinical Practice
|
October 29, 2008
Inhibition of advanced glycation end products (AGEs): an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Toshio Miyata, Takashi Dan
Advances in Renal Replacement Therapy
|
December 19, 2003
Advanced glycation end products in uremia
Thomas Henle, Toshio Miyata
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 4, 2007
Toward better renoprotection: lessons from angiotensin receptor blockers
Toshio Miyata, Shunya Takizawa
Internal Medicine (Tokyo, Japan)
|
January 13, 2004
A detective story for biomedical footprints towards new therapeutic interventions in diabetic nephropathy
Toshio Miyata, Kiyoshi Kurokawa
Annals of the New York Academy of Sciences
|
May 2, 2008
Inhibition of advanced glycation end products: an implicit goal in clinical medicine for the treatment of diabetic nephropathy?
Toshio Miyata, Yuko Izuhara
Cells
|
May 27, 2026
Plasminogen Activator Inhibitor-1 as a Therapeutic Target for Healthy Longevity, Immunosenescence, and Age-Related Disease: Translational Development of the Small-Molecule Inhibitor TM5614
Mohamed Abdelhakim, Toshio Miyata
Amino Acids
|
October 21, 2010
Early- and advanced non-enzymatic glycation in diabetic vascular complications: the search for therapeutics
Casper G Schalkwijk, Toshio Miyata
Page
of 22